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INTRODUCTION
There has been recognition of the impor-
tance of social science perspectives during 
emergent epidemics over the past 30 years, 
especially the HIV pandemic and the West 
African Ebola Epidemic between 2014 and 
2016.1 However, the COVID-19 response 
continues to be driven by epidemiological 
priorities and one- size- fits- all approaches. 
What the pandemic has made explicit is that 
despite countries organising preparedness 
programmes according to global policy, the 
differences in implementation and uptake 
are vast due to local politics, health systems 
and other contextual factors. Social science 
brings an understanding of context and 
draws attention to politics, power and social 
difference with implications for epidemic 
response. Furthermore, and in light of the 
imperative to decolonise global health, social 
science can bring diverse and decolonised 
perspectives to the table, which can localise 
and ground health policy.
Our multinational social science working 
group under the COVID-19 Clinical Research 
Coalition has established four intersecting 
priorities as essential areas for shaping 
social science research and global policy for 
COVID-19 in the long term. We argue that 
these priorities are crucial to the ethical 
conduct of biomedical research and public 
health policy and also relevant to broader 
historical, social, political, and economic 
debates on COVID-19.
PRIORITY 1: POLITICAL ECONOMY
The political dimensions of the pandemic, 
and the ways in which political economies 
shape pandemic responses and access to care, 
have been the dominant theme during the 
pandemic.2 One key aspect of the COVID-19 
pandemic is the intensifying of deep 
pre- existing structures of inequality across 
geographic scales. The spread of the virus 
has been concentrated in areas where social 
determinants of health, such as low educa-
tion level, precarious socioeconomic situa-
tion, discrimination and structural racism, 
contribute to adverse health outcomes. 
Hence, disparities (eg, ethnic, class, income) 
observed in COVID-19 cases are a symptom 
of systemic inequality that is intertwined with 
biology, health behaviours and everyday living 
environments.2
Summary box
 ► The COVID-19 response continues to be driven by 
epidemiological priorities, and yet, the epidemic 
and responses are situated within specific political 
and health system contexts. Social science brings 
an understanding of context and draws attention to 
politics, power and social difference.
 ► There are four critical social science priorities for 
COVID-19 research and policy in the long term. First, 
political- economic insights can support the design 
of public health measures and elucidate how public 
health responses are produced by political systems.
 ► Second, a better understanding of the political and 
social structures that relate to vaccine confidence 
will improve public trust, acceptability, effectiveness 
and uptake of COVID-19 vaccines and therapeutics.
 ► Third, development of social science perspectives 
on health and governance is vital to inform and un-
tangle the complicated ways in which nationalism 
interacts with public health measures.
 ► Finally, social science inquiry can reveal how indi-
viduals and communities perceive, understand and 
construct COVID-19 risk and severity and seek help.
 ► These insights support building trust and good re-
lations between local and international research 
and programme teams and between communities 
and researchers that will enhance confidence in the 
development, research and deployment of vaccines 
and other COVID-19 control measures.
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Alongside the emphasis on institutions and policy, social 
science brings attention to power dynamics in everyday 
relations. Paying attention to everyday experiences of 
and social responses to the crisis, social science research 
can reveal how COVID-19 affects and is affected by local 
power dynamics. During the 2014–2016 West African 
Ebola epidemic, for example, anthropologists studied 
local legitimacy and formal and informal authority struc-
tures illuminated both the challenges and opportuni-
ties for mobilising communities in responding to the 
epidemic.3 Tensions between national and local leader-
ship across European countries during COVID-19 high-
light the need for similar efforts to map power dynamics 
and identify entry points for effective community engage-
ment. Overall, social science research can observe how 
political and economic dynamics contribute to the doing 
and undoing of public confidence in response measures. 
On vaccine equity, social science can highlight the poli-
tics behind technical discussions on intellectual property 
rights.4 5
A key priority for long- term COVID-19 response then 
is to understand the multiple political determinants of 
institutional responses and of individual and collec-
tive experiences of the pandemic. These insights can 
include an appreciation of how political trends such as 
the growth of nationalist populism affect the standing of 
scientific evidence,2 how political networks influence the 
awarding of public contracts for implementing response 
measures or how the health crisis has prompted recon-
figurations and reckonings in long- standing struggles for 
racial justice. A focus on political economy will involve 
exploring the infrastructures of pandemic response at 
national and global levels, focusing on how the distribu-
tion of power and resources across actors and organisa-
tions influences COVID-19 public health responses and 
outcomes. We can trace institutional priorities, funding 
mechanisms and decision- making processes. Political–
economic insights can support the design of public health 
measures and elucidate how public health responses are 
produced by political systems in ways that have direct 
health outcomes.
PRIORITY 2: CLINICAL TRIALS, VACCINE DEPLOYMENT AND 
VACCINE EQUITY
The COVID-19 pandemic has raised a range of social 
science issues related to clinical trials of COVID-19 ther-
apeutics and vaccines, including for COVID-19 therapeu-
tics and vaccines.6 7 Trust in clinical research is directly 
related to vaccine deployment, as trials pave the way for 
how vaccines and therapeutics are perceived and taken 
up. While vaccine trials adhere to international and 
local bioethical standards, local concerns about medical 
research are contingent on local cultural norms and 
values, reflect previous experiences of research and are 
influenced by existing health systems. For example, under-
standing local power dynamics, ideas of fairness and the 
nature of trust has been important for the recruitment 
of participants into Ebola vaccine trials.8 Conducting 
clinical research in an epidemic, when people are under-
standably fearful, also requires an appreciation of what 
motivates people to take part in trials. Fears and mistrust 
can be expressed through rumours, gossip and conspiracy 
theories.9 Building good relations between researchers 
and communities requires engaging with these concerns. 
The Ebola vaccine trials have taught us the importance 
of altruism, sacrifice, curiosity and hope, in participants’ 
decision- making, even despite their fear.10
Vaccine confidence is also influenced by historical, 
cultural and political dynamics. Social relations, trust and 
legitimacy are particularly important.11 Social science 
inquiry can reveal how governments and COVID-19 
country coordinating bodies can improve public trust, 
acceptability, effectiveness and uptake of COVID-19 
vaccines and therapeutics. Ebola research has demon-
strated that the roots of mistrust extend beyond the 
epidemic, making acceptability contingent on past rela-
tions between communities, healthcare providers and 
international agencies. To build vaccine confidence, it is 
important to take these voices seriously and address misin-
formation and disinformation that affect vaccine uptake. 
Effective community engagement should be systematised 
for COVID-19 clinical trials and vaccine deployment.
Social science inquiry also brings attention to social 
justice in access to COVID-19 vaccines in resource poor 
contexts. COVAX has not secured sufficient vaccine 
supplies and it is clear that a charity model for vaccine 
equity does not work. Thus, a second key priority is to 
understand political and social structures that relate to 
vaccine development and deployment. A key concern is 
the pricing of vaccines that is determined by intellectual 
trade- related property rights agreements, which means 
that novel, patent- protected products tend to be over the 
price range that low- income countries can afford.4 5 This 
raises long- term questions about research and produc-
tion infrastructures that are influenced by political histo-
ries and contemporary realities. The development of 
COVID-19 vaccines and subsequent protection of intel-
lectual property raise questions about the use of public 
funds to develop privatised technologies.12
PRIORITY 3: TRANSNATIONALISM
In the early days of the pandemic, border after border 
was closed as one of the first measures instituted to stop 
the virus’ spread. Nations rushed to stockpile limited 
COVID-19 vaccines at the expense of equity and fair-
ness. While this was a visible result of national measures 
to control the spread of COVID-19, it also linked into 
broader concerns around underlying nationalism that 
has been exacerbated and manifested in public health 
emergency response. Nationalist- driven policies reaf-
firm and strengthen borders, which present challenges 
to transnational or regional collaboration.8 There-
fore, social science perspectives are vital to inform and 
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untangle the complicated ways in which nationalism 
interacts with public health measures.
A third key priority is to develop social science perspec-
tives on health and governance related to nationalism 
and transnational populations. Critically, the focus 
should move beyond national borders to understand how 
transnational communities are complex and shifting. 
There is a need to explore the interplay between nation-
alism and the pandemic. This will involve exploring how 
transnational populations are affected by dynamics of the 
pandemic, nationalism and national- level public health 
response.
PRIORITY 4: PREVENTATIVE AND HEALTH-SEEKING BEHAVIOUR
Uncertainties around the COVID-19 pandemic, and 
the political–economic context affect public trust in the 
COVID-19 response and formal and informal health-
care providers.13 Trust in public health actors is essential 
for healthcare seeking for COVID-19. The public and 
expert discourses on COVID-19 are multiple and often 
conflicting, driving a crisis of legitimacy, trust and uncer-
tainty. Thus, it is crucial to explore how individuals and 
communities perceive, understand, construct, COVID-19 
risk and severity. This requires an exploration of how past 
experiences of epidemics affect individuals’ preventative 
or treatment- seeking behaviour and the role of COVID-19 
stigma.14 Social science inquiry can reveal how social 
inequalities shape discriminatory practices and affect 
healthcare access and ability of individuals to protect 
themselves from risk of COVID-19.15 As more cases of 
long COVID-19 emerge, social science approaches will 
be needed to understand the long- term health effects 
and political, social and economic impacts including 
stigma drawing on social science perspectives on HIV as a 
chronic disease. Finally, social science inquiry can reveal 
how the COVID-19 response has affected health- seeking 
behaviour for other non- COVID medical needs.
CONCLUSION
As the COVID-19 pandemic has revealed, biomedical and 
behavioural approaches to public health are insufficient 
on their own to tackle inequities that have become so 
apparent. The pandemic is fundamentally a sociopolit-
ical problem. While medical technologies like vaccines 
have been developed rapidly and will be key to ending the 
pandemic, ending the pandemic for all and bolstering 
recovery will require tackling some of the most important 
social, political, economic and social justice questions of 
our time and social science can provide crucial insights 
into how to do this.
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